Close Menu

IBM

Clinicians in the hospital will use IBM's Watson to identify possible options for diagnosing and treating rare pediatric diseases starting with kidney disease.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

The partners will use Watson's cognitive capabilities to reduce to minutes from weeks the translation of DNA information to create a genetic profile of a patient.

Gathering the Data

IBM and its partners look to combine health information to develop a health platform for the Watson supercomputer.

The partners created a consortium that will perform a metagenomics study into the role that microorganisms play in a "normal, safe factory environment." 

Pathway Genomics is developing a mobile application that will use IBM's Watson technology to couple individuals' health and genetic information with data from peer-reviewed medical journal articles and clinical trials to provide personalized feedback in response to users' wellness-related queries.

NEW YORK (GenomeWeb) – The IBM Watson Group has made an investment of an undisclosed amount in Pathway Genomics, a clinical genetic testing services laboratory, that will support efforts to develop a Watson-powered mobile application called Pathway Panorama.

NEW YORK (GenomeWeb) – IBM said today that it has partnered with the Cleveland Clinic to evaluate the use of its Watson supercomputer in a personalized oncology program at the clinic.

NEW YORK (GenomeWeb) – Researchers from the University of New South Wales in Australia and the Oswaldo Cruz Foundation (Fiocruz) in Brazil will use IBM's World Community Grid — a collection of crowd-sourced computers volunteered by thousands of individuals — to analyze millions of protein-coding

SAN DIEGO (GenomeWeb) – While genomics has showed promise at a small scale for matching patients to treatments, scaling that capability up so that personalized medicine may be realized for all will require a lot more data to be sifted through, speakers at this year's American Society of Human Gen

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.